The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice

Measurable residual disease (MRD) is being recognised as an optimal method for assessing depth of response, identifying higher risk of relapse, and guiding response-based treatment paradigms for multiple myeloma (MM). Although MRD negativity is increasingly replacing complete response as the surroga...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Rose, Kalff, Anna, Bergin, Krystal, Gorniak, Malgorzata, Fleming, Shaun, Spencer, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159389/
https://www.ncbi.nlm.nih.gov/pubmed/35664737
http://dx.doi.org/10.3389/fonc.2022.820605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159389/
https://www.ncbi.nlm.nih.gov/pubmed/35664737
http://dx.doi.org/10.3389/fonc.2022.820605

Ejemplares similares